Compounders complain they can't make these four drugs ...

bioprocessintl.com › bioprocess-insider › regulations › compounders-...

2 days ago - After 23 March, the US FDA won’t allow any more bulk compounding of four oft-compounded drug substances, disrupting patient care, compounders say. ... The announcement said outsourcing facilities complained four substances on the FDA’s preliminary list would be affected by the ...